Aerobic Exercise in Women With Gestational Diabetes

NCT ID: NCT03067662

Last Updated: 2021-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-27

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A few, small randomized controlled trials have investigated the effects of exercise on blood glucose levels in women with gestational diabetes (GDM), with inconsistent results.

To assess the effects of supervised exercise in women with GDM, 48 women with gestational diabetes, diagnosed between the 18th and 28th week of gestation, will be recruited, after exclusion of subjects with contraindications to exercise. These subjects will be randomly assigned to two groups: structured exercise intervention or standard care.

Women in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (heart rate reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (increasing 2 min/week). Women in the control group will receive standard diet and physical exercise recommendations.

In all women, clinical, metabolic and anthropometric features will be assessed before, during and at the end of the study. Newborn data will also be collected.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Mellitus in Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supervised exercise intervention

Women in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (Heart Rate Reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (by increasing 2 min/week).

Group Type EXPERIMENTAL

Aerobic exercise

Intervention Type OTHER

Current standard of care

Women in the control group will receive standard physical exercise recommendations.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic exercise

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Singleton pregnancy,
* Gestational diabetes diagnosis between 18th and 28th week of gestation,
* Caucasian.

Exclusion Criteria

* Hemodynamically significant heart disease,
* Restricted lung disease,
* Incompetent cervix/cerclage,
* Persistent second or third trimester bleeding,
* Placenta previa,
* Threatened preterm labor,
* Ruptured membranes,
* Preeclampsia,
* Hypertension,
* Severe anemia,
* Cardiac arrhythmias,
* History of epilepsy,
* Chronic bronchitis,
* Orthopedic limitations,
* Overt hyperthyroidism/ hypothyroidism,
* Type 1 diabetes mellitus,
* Drugs that interfere with metabolic control (such as cortisone)
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universita di Verona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paolo Moghetti

Associate Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paolo Moghetti, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Endocrinology, Diabetes and Metabolism Section, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona

Verona, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paolo Moghetti, MD, PhD

Role: CONTACT

Silvia DonĂ , MSC

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paolo Moghetti

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2152

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glucose Control in Type 2 Diabetes in Pregnancy
NCT07250698 NOT_YET_RECRUITING NA
Physical Activity in Pregnancy
NCT03277807 COMPLETED